ABEC
Private Company
Total funding raised: $50M
Overview
ABEC is a privately held, established player in the bioprocess manufacturing sector, providing critical capital equipment and services to biopharmaceutical companies. Its unique value proposition lies in its combination of deep engineering expertise, extensive in-house manufacturing capacity, and flexibility, enabling clients to accelerate their time to market. The company is a key enabler for the industry's shift towards single-use technologies, holding notable claims such as manufacturing the largest single-use bioreactor and offering the shortest lead times for single-use containers.
Technology Platform
Integrated provider of stainless steel and single-use bioprocess equipment, engineering, and services. Core platform includes the Custom Single Run (CSR®) single-use systems, large-scale bioreactor design, and full lifecycle support from process engineering to maintenance.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
ABEC competes in a crowded market with major players like Sartorius, Thermo Fisher Scientific, Danaher (Cytiva), and Merck Millipore. Its differentiation is based on deep customization expertise, claimed industry-leading manufacturing capacity and lead times, and a focus on large-scale production equipment, particularly for single-use systems.